Skip to main content
. 2023 Feb 9;141(3):275–283. doi: 10.1001/jamaophthalmol.2022.6254

Figure 3. Low-Luminance Visual Acuity (VA) in Dosed and Untreated Eyes in the Clinical Trial of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Using BIIB112 (XIRIUS) Study Part 1.

Figure 3.

A, Gain in low-luminance VA Early Treatment Diabetic Retinopathy Study (ETDRS) score greater than or equal to 10 letters. B, Gain in low-luminance VA ETDRS score greater than or equal to 15 letters. The shading in panels A and B indicates the difference between the dosed and untreated eye.